PCNA Antibody, anti-human/mouse/rat, REAfinity™
Synonyms: proliferating-cell-nuclear-antigen, Cyclin
RECOMBINANT EXTENDED VALIDATION
Bioz Star94/100 Bioz rating
4 Citations
Clone:
REA858 | PC10
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for PCNA Antibody, anti-human/mouse/rat, REAfinity™

Intracellular flow cytometry applications
APC
FITC
PE
Vio B515
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-114-513, 130-114-704
Description:
Jurkat cells were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were then stained with Anti-PCNA antibodies or with the corresponding REA Control (I) antibodies (left peak) and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application image
MICS (MACSima Imaging Cyclic Staining) applications
APC
FITC
PE
Fixation:
FFPE
Species tested:
human
Tissue used:
tonsil
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-114-513, 130-114-704
Testing grade:
Description:
Immunofluorescence analysis of a formalin-fixed, paraffin-embedded (FFPE) tonsil section. Before staining, antigens were retrieved using heat-induced epitope retrieval (HIER) at pH 9. The section was stained using PCNA APC (green) for 10 minutes at room temperature. Sample detail image (A), overview image (B). Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm.

A

Application imageView details view details

B

Application imageView details view details
Fixation:
frozen – Acetone
Species tested:
mouse
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-114-513, 130-114-704
Testing grade:
Extended validation for PCNA Antibody, anti-human/mouse/rat, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA858
PC10 (3F81)
partial
PC10
partial
D3H8P
low

Cells were incubated with an excess of purified unconjugated PCNA (REA858) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for PCNA. Jurkat cells were stained with a suitable counterstaining followed by a fixation and permeabilization step using Cell Signaling Buffer Set A. Cells were then stained with PCNA antibodies. As a control, PCNA antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris and cell doublets were excluded from the analysis based on scatter signals. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.

Specifications for PCNA Antibody, anti-human/mouse/rat, REAfinity™
Overview

Clone REA858 recognizes the human, mouse, and rat proliferating cell nuclear antigen (PCNA), a 36 kDa nuclear protein also known as cyclin or auxiliary protein of DNA polymerase delta. PCNA is expressed in the nucleus of all proliferating cells. PCNA plays a role in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand. Furthermore, it is involved in DNA damage response by being conveniently positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways.

Additional information: Clone REA858 displays negligible binding to Fc receptors.

Alternative names

proliferating-cell-nuclear-antigen, Cyclin

Detailed product information

Technical specifications

Clone
REA858
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse, rat, non-human primate, other
Cross-reactivity
cynomolgus monkey (Macaca fascicularis), rhesus monkey (Macaca mulatta), chicken, rabbit, hamster, horse, sheep, dog, cat, ferret, xenopus
Antigen
PCNA
Molecular mass of antigen [kDa]
29, same molecular weight for human and mouse/rat
Entrez Gene ID
RRID
AB_2726681, AB_2726682, AB_2726765, AB_2726766, AB_2726679, AB_2726763, AB_2726680, AB_2726764

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for PCNA Antibody, anti-human/mouse/rat, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?